NCT05835453

Brief Summary

The aim of this project is to clinically evaluate patient satisfaction, whitening efficacy, tooth sensitivity, and gingival irritation during at-home whitening with 10% carbamide peroxide using an Essix-type retainer or a Vivera retainer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 28, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

September 14, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2024

Completed
Last Updated

October 3, 2025

Status Verified

October 1, 2025

Enrollment Period

3 months

First QC Date

April 18, 2023

Last Update Submit

October 1, 2025

Conditions

Keywords

At-home tooth bleachingClear alignerTooth sensitivityGingival irritationPatient´s satisfaction

Outcome Measures

Primary Outcomes (1)

  • Patient´s satisfaction

    It will be measured with a questionnaire using a visual analog scale (EVA), when a essix-type retairner or Vivera retainer is used to perform a at home bleaching treatment with 10% carbamide peroxide.

    Baseline, after one, two and four weeks

Secondary Outcomes (3)

  • Color change evaluation

    Baseline, after one, two and four weeks

  • Intensity and absolute risk of tooth sensitivity

    Baseline, after one, two, four weeks, and at 1 month after bleaching treatment

  • Intensity and absolute risk of gingival irritation

    Baseline, after one, two, four weeks, and at 1 month after bleaching treatment

Study Arms (2)

Essix-type retairner

ACTIVE COMPARATOR

Two simple randomizations will be performed using a software program freely available online (www.sealedenvelop.com). For the first randomization, for each participant, the group (type of tray) will be randomized and it will always be applied to the participant's right hemiarch (n=40) according to the model: essix-type retairner or Vivera retainer. Subsequently, the second randomization will be carried out, which will define the alternate days for the use of essix-type retairner and Vivera retainer: Monday, Wednesday and Friday or Tuesday, Thursday and Saturday.

Other: Whitening

Vivera retainer

ACTIVE COMPARATOR

The patients will use the clear aligner on their right hemiarch and according to the second randomization it will be applied on Monday, Wednesday and Friday or Tuesday, Thursday and Saturday.

Other: Whitening

Interventions

Two syringes of 10% carbamide peroxide bleaching gel will be provided for use with each type of tray. Volunteers will be instructed to use the whitening gel once a day for 2 hours, for 3 days per week with each retainer, completing a total of 4 weeks of whitening procedure.

Essix-type retairnerVivera retainer

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age.
  • Patients with vital teeth without restorations, single crowns, implants and/or bridges at the level of the anterior teeth.
  • Absence of cavities in the teeth to be whitened.
  • Patients with satisfactory oral hygiene, and periodontally healthy, who are not undergoing periodontal maintenance and who do not use chlorhexidine rinses. Patients with recessions without sensitivity are included.
  • Absence of sensitivity, measured based on stimulation with the air from the syringe.
  • Patients who are at least in A2-A3 color (Vita Classic Guide)

You may not qualify if:

  • Patients who have previously undergone whitening (less than 5 years).
  • Patients undergoing orthodontic treatment.
  • Patients with white spot or developmental alterations (dentinogenesis imperfecta, amelogenesis imperfecta) or with stains (tetracyclines or fluorosis).
  • Patients with a history of trauma to anterior teeth.
  • Patients who require internal whitening.
  • Smokers.
  • Pregnant or lactating women.
  • Allergy to any component of whitening.
  • Alterations of the oral mucosa (desquamative gingivitis, OLP, leukoplakias, etc.).
  • Medical conditions considered by the researchers that may compromise the study or the individual safety of the patient.
  • Patients with poor oral hygiene.
  • Patients with previous hypersensitivity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Dental Iturralde

Tafalla, Navarre, 31300, Spain

Location

Related Publications (2)

  • Almeida LC, Riehl H, Santos PH, Sundfeld ML, Briso AL. Clinical evaluation of the effectiveness of different bleaching therapies in vital teeth. Int J Periodontics Restorative Dent. 2012 Jun;32(3):303-9.

    PMID: 22408775BACKGROUND
  • Carneiro TS, Favoreto MW, Bernardi LG, Sutil E, Wendlinger M, Centenaro GG, Reis A, Loguercio AD. Gingival irritation in patients submitted to at-home bleaching with different cutouts of the bleaching tray: a randomized, single-blind clinical trial. Clin Oral Investig. 2022 Jun;26(6):4381-4390. doi: 10.1007/s00784-022-04401-4. Epub 2022 Feb 7.

    PMID: 35128627BACKGROUND

MeSH Terms

Conditions

Tooth DiscolorationDentin SensitivityGingivitisPatient Satisfaction

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesInfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
It will be a single-blind study in which only the evaluator will not know the designation of the groups because he has not participated in the study's randomization and implementation process. Due to the tray test and demonstration of the bleaching procedure, the operator and the participant cannot be blinded.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a randomized, single blind (evaluators), split mouth and equivalence study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 18, 2023

First Posted

April 28, 2023

Study Start

September 14, 2023

Primary Completion

December 15, 2023

Study Completion

December 10, 2024

Last Updated

October 3, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations